Bone Cancer Treatment Market Size

Statistics for the 2023 & 2024 Bone Cancer Treatment market size, created by Mordor Intelligence™ Industry Reports. Bone Cancer Treatment size report includes a market forecast to 2029 and historical overview. Get a sample of this industry size analysis as a free report PDF download.

Market Size of Bone Cancer Treatment Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
bone cancer treatment market
Study Period 2019 - 2029
Market Size (2024) USD 1.22 Billion
Market Size (2029) USD 1.58 Billion
CAGR (2024 - 2029) 5.27 %
Fastest Growing Market North America
Largest Market North America

Major Players

bone metastasis treatment market trends

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Bone Cancer Treatment Market Analysis

The Bone Cancer Treatment Market size is estimated at USD 1.22 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 5.27% during the forecast period (2024-2029).

During the early stages of COVID-19, there was a significant reduction in the number of cases treated in the musculoskeletal oncology departments, which has affected the number of surgical volumes. The massive reduction in musculoskeletal oncology services may have drastic consequences for affected patients and the overall market growth. However, several precautionary guidelines were issued by the respective government authorities to initiate the delayed or postponed bone cancer treatments, enabling patients to acquire safe access to treatment during the COVID-19 pandemic.

Certain factors driving the market growth include the increasing global burden of bone cancer and government initiatives for bone cancer awareness. The incidence of bone cancer is on a steady rise and needs to be addressed at the earliest to reduce the burden of bone sarcoma across the world.

According to estimates by the American Society of Clinical Oncology, the United States is estimated to witness 3,610 new cases of bone cancer and an expected 2,060 deaths due to bone cancer in 2021. The chemotherapeutic drugs approved for the treatment of bone cancer do not have an effective treatment regime, as it always varies according to the prevailing conditions and the way the patient's body responds to the drug. Hence, the associated side effects, risks, and limitations of the treatment are limiting the growth of the bone cancer treatment drug market.

Bone Cancer Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)